Stocks and Investing Stocks and Investing
Thu, May 5, 2016
Wed, May 4, 2016
Tue, May 3, 2016

David Risinger Maintained (TEVA) at Buy with Decreased Target to $69 on, May 3rd, 2016


Published on 2024-10-25 12:32:47 - WOPRAI, David Risinger
  Print publication without navigation


David Risinger of Morgan Stanley, Maintained "Teva Pharmaceutical Industries Limited" (TEVA) at Buy with Decreased Target from $71 to $69 on, May 3rd, 2016.

David has made no other calls on TEVA in the last 4 months.



There are 2 other peers that have a rating on TEVA. Out of the 2 peers that are also analyzing TEVA, 0 agree with David's Rating of Hold.



These are the ratings of the 2 analyists that currently disagree with David


  • Jacob Hughes of "Wells Fargo" Initiated at Buy on, Friday, February 19th, 2016
  • Gregg Gilbert of "Deutsche Bank" Maintained at Strong Buy with Decreased Target to $80 on, Friday, February 12th, 2016

Contributing Sources